Listings in the U.S. and USA
QIAGEN’s common shares have been registered and traded in the United States since 1996, listing on the New York Stock Exchange effective January 10, 2018, after trading on NASDAQ markets since the initial public offering (IPO). The shares have traded in Germany on the Frankfurt Stock Exchange since 1997, and the Prime Standard segment since its launch in 2003. Dual listing on NYSE and the Frankfurt exchange offers advantages for QIAGEN, our shareholders and employees since global presence increases the potential market opportunity and enhances liquidity. Unlike American Depositary Receipts (ADRs), QIAGEN shares provide equal corporate rights for all shareholders and can be traded on either exchange, in U.S. dollars or euros.
| New York Stock Exchange (NYSE) |
2025 |
2024 |
2023 |
2022 |
2021 |
| Year-end price |
$44.97 |
$44.53 |
$43.43 |
$49.87 |
$55.58 |
| High |
$51.88 |
$47.44 |
$51.18 |
$55.12 |
$59.00 |
| Low |
$37.63 |
$39.03 |
$34.74 |
$40.38 |
$45.58 |
| Average daily trading volume (in million shares) |
1.32 |
1.12 |
1.02 |
0.91 |
0.79 |
| Frankfurt Stock Exchange (XETRA) |
2025 |
2024 |
2023 |
2022 |
2021 |
| Year-end price |
€38.66 |
€43.05 |
€39.40 |
€47.01 |
€48.99 |
| High |
€46.21 |
€44.13 |
€48.36 |
€49.37 |
€51.56 |
| Low |
€32.50 |
€36.59 |
€32.74 |
€37.95 |
€37.38 |
| Average daily trading volume (in million shares) |
0.54 |
0.54 |
0.51 |
0.54 |
0.56 |
Index Membership
QIAGEN is included in major stock indices in the U.S. and Europe. In Europe, QIAGEN is a member of the DAX and TecDAX indices. QIAGEN became a member of the DAX on September 20, 2021.
In the U.S., QIAGEN is included in the Russell 3000 Index and the Russell 1000 Index.
| Key share data |
2025 |
2024 |
2023 |
2022 |
2021 |
| Total equity (in $ thousands) |
3,778,154 |
3,567,339 |
3,807,764 |
3,466,611 |
3,096,550 |
| Issued shares (in thousands) |
217,685 |
223,904 |
230,829 |
230,829 |
230,829 |
| Outstanding shares at December 31 (in thousands) |
216,921 |
222,291 |
228,203 |
227,716 |
227,074 |
| Weighted-average number of common shares outstanding - basic (in thousands) |
217,219 |
222,619 |
228,146 |
227,577 |
227,983 |
| Weighted-average number of common shares outstanding - diluted (in thousands) |
218,880 |
224,717 |
230,619 |
230,136 |
232,034 |
| Year-end market capitalization (in $ million) |
9,755 |
9,899 |
9,911 |
11,356 |
12,621 |
| Year-end market capitalization (in € million) |
8,385 |
9,569 |
8,991 |
10,705 |
11,124 |
| Free Float (in %) |
99.54 |
99.55 |
99.59 |
99.64 |
99.68 |